New tumour biobank powers personalised cancer treatments
Posted: 22nd March 2022
Categories: Industry news
Scientists have discovered new and more effective ways of growing breast cancer tumours that could accelerate research and the development of new treatments. Instead of transplanting human tumours into mice, they’ve developed a bank of “human patient-derived xenografts (PDXs)” that can be used to screen drugs. Used alongside personalised genetic tests could improve cancer treatment […]
SOTs effective at treating cancer in 77% of patients
Posted: 9th March 2022
Categories: RGCC news
Cancer patients treated with the highly targeted supportive oligonucleotide therapy (SOT) showed benefits in 77% of cases, RGCC scientists have found. A new paper published in the in vivo journal finds evidence that SOTs effectively target and kill cancer cells on their own or in tandem with other therapies. Supportive oligonucleotide therapy is an advanced, […]